NCT05751668 2026-04-07
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Alliance for Clinical Trials in Oncology
Phase 2 Suspended
Clinical Trials
27 trialsNCT03077841 2026-03-05
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
M.D. Anderson Cancer Center
Phase 2/3 Suspended
NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT05315011 2025-12-03
CRYOMATASE
University Hospital, Montpellier
Phase NA Suspended
NCT07178665 2025-11-14
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Rutgers, The State University of New Jersey
Phase 1 Suspended
NCT06491654 2025-06-11
Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
European University Miguel de Cervantes
Phase NA Suspended
NCT06121453 2025-05-22
Adherence Intervention in Patients With Metastatic Breast Cancer
Columbia University
Phase NA Suspended
NCT04973930 2025-05-13
IPT
New York State Psychiatric Institute
Phase 3 Suspended
NCT06214793 2025-05-01
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Case Comprehensive Cancer Center
Phase 2 Suspended
NCT04339517 2025-03-28
Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Suspended
NCT04151368 2025-01-31
RNSM
University Health Network, Toronto
Phase NA Suspended
NCT02037529 2024-08-20
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Academic and Community Cancer Research United
Phase 3 Suspended
NCT04946864 2024-08-19
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Ascentage Pharma Group Inc.
Phase 1/2 Suspended
NCT04120246 2024-07-10
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Veana Therapeutics
Phase 1 Suspended
NCT04714983 2024-04-09
DNX-2440 for Resectable Colorectal Liver Metastasis
DNAtrix, Inc.
Phase 1 Suspended
NCT04650451 2023-04-20
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Bellicum Pharmaceuticals
Phase 1 Suspended
NCT03130946 2022-10-18
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
Peking University People's Hospital
Phase NA Suspended
NCT04116281 2022-07-12
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
Universidade Federal de Sao Carlos
Phase NA Suspended
NCT02897050 2022-04-20
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Suspended
NCT04683120 2021-06-30
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Laser LabCorp
Phase NA Suspended
NCT00738777 2021-01-22
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2 Suspended
NCT03845907 2020-04-06
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications
Seno Medical Instruments Inc.
Phase NA Suspended
NCT01589861 2017-03-28
PIKHER2
Institut Paoli-Calmettes
Phase 1/2 Suspended
NCT00673829 2016-06-17
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Roger Williams Medical Center
Phase 1 Suspended
NCT00002696 2013-08-02
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Suspended
NCT01122342 2010-05-13
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
University of Vermont
Phase 1/2 Suspended
NCT00909558 2010-02-24
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Phase 1 Suspended